Predicting the impact of physiological and biochemical processes on oral drug bioavailability

被引:437
作者
Agoram, B
Woltosz, WS
Bolger, MB
机构
[1] Simulat Plus Inc, Lancaster, CA 93524 USA
[2] Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA
关键词
carrier-mediated transport and efflux; saturable P450 metabolism; in silico simulation; drug absorption;
D O I
10.1016/S0169-409X(01)00179-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent advances in computational methods applied to the fields of drug delivery and biopharmaceutics will be reviewed with a focus on prediction of the impact of physiological and biochemical factors on simulation of gastrointestinal absorption and bioavailability. Our application of a gastrointestinal simulation for the prediction of oral drug absorption and bioavailability will be described. First, we collected literature data or we estimated biopharmaceutical properties by application of statistical methods to a set of 2D and 3D molecular descriptors. Second, we integrated the differential equations for an advanced compartmental absorption and transit (ACAT) model in order to determine the rate, extent, and approximate gastrointestinal location of drug liberation (for controlled release), dissolution, passive and carrier-mediated absorption, and saturable metabolism and efflux. We predict fraction absorbed, bioavailability, and CP vs. time profiles for common drugs and compare those estimates to literature data. We illustrate the simulated impact of physiological and biochemical processes on oral drug bioavailability. (C) 2001 Elsevier Science BY. All rights reserved.
引用
收藏
页码:S41 / S67
页数:27
相关论文
共 107 条
[1]   PASSIVE DIFFUSION OF WEAK ORGANIC ELECTROLYTES ACROSS CACO-2 CELL MONOLAYERS - UNCOUPLING THE CONTRIBUTIONS OF HYDRODYNAMIC, TRANSCELLULAR, AND PARACELLULAR BARRIERS [J].
ADSON, A ;
BURTON, PS ;
RAUB, TJ ;
BARSUHN, CL ;
AUDUS, KL ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1197-1204
[2]   THE INTESTINAL DIALYSIS OF INTRAVENOUSLY ADMINISTERED PHENYTOIN BY ORAL ACTIVATED-CHARCOAL IN RATS [J].
ARIMORI, K ;
NAKANO, M .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1987, 10 (04) :157-165
[3]   Drug exsorption from blood into the gastrointestinal tract [J].
Arimori, K ;
Nakano, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :371-376
[4]   CLINICAL PHARMACOKINETICS OF DIGOXIN 1980 [J].
ARONSON, JK .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :137-149
[5]   IMMUNOMODULATING PROPERTIES OF 5,20-ALPHA (R)-DIHYDROXY-6-ALPHA,7-ALPHA-EPOXY-1-OXO-(5-ALPHA)-WITHA-2,24-DIENOLIDE AND SOLASODINE [J].
BAHR, V ;
HANSEL, R .
PLANTA MEDICA, 1982, 44 (01) :32-33
[6]   LOCALIZATION, DISTRIBUTION, AND INDUCTION OF XENOBIOTIC-METABOLIZING ENZYMES AND ARYL-HYDROCARBON HYDROXYLASE-ACTIVITY WITHIN LUNG [J].
BARON, J ;
VOIGT, JM .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (03) :419-445
[8]   Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling [J].
Bogaards, JJP ;
Hissink, EM ;
Briggs, M ;
Weaver, R ;
Jochemsen, R ;
Jackson, P ;
Bertrand, M ;
van Bladeren, PJ .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) :117-124
[9]   HUMAN CYTOCHROMES-P-450 [J].
BOOBIS, AR ;
DAVIES, DS .
XENOBIOTICA, 1984, 14 (1-2) :151-185
[10]   MULTIPLE FORMS OF HUMAN CYTOCHROME-P-450 [J].
BOOBIS, AR ;
DAVIES, DS .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1984, 12 (01) :78-80